You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for 1-EBIO
1-EBIO is an activator of epithelial KCa channels, stimulates a large and sustained trans-epithelial Cl- secretory response across T84 monolayers. Induces hyperpolarization to the same magnitude as ACh in aortic value endothelial cells. Promotes embryonic stem cell (ESC) differentiation into cardiomyocytes.
Compound Libraries for 1-EBIO
Technical Data for 1-EBIO
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for 1-EBIO
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for 1-EBIO
The following data is based on the product molecular weight 162.19. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||6.17 mL||30.83 mL||61.66 mL|
|5 mM||1.23 mL||6.17 mL||12.33 mL|
|10 mM||0.62 mL||3.08 mL||6.17 mL|
|50 mM||0.12 mL||0.62 mL||1.23 mL|
References for 1-EBIO
References are publications that support the biological activity of the product.
Ayotunde and Adeagbo (1999) 1-Ethyl-2-benzimidazolinone stimulates endothelial KCa channels and nitric oxide formation in rat mesenteric vessels. Eur.J.Pharmacol. 379 151 PMID: 10497901
Devor et al (1996) Modulation of Cl- secretion by benzimidazolones. I. Direct activation of a Ca2+ - dependent K+ channel. Am.J.Physiol. 271 L775 PMID: 8944721
Kusama et al (2005) Reduced hyperpolarisation in endothelial cells of rabbit aortic value following chronic nitroglycerine administration. Br.J.Pharmacol. 146 487 PMID: 16056232
Kleger et al (2010) Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation. 122 1823 PMID: 20956206
If you know of a relevant reference for 1-EBIO, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: 1-EBIO, 1-EBIO supplier, Activator, epithelial, Kca, channels, Potassium, Channels, ca2+-activated, ca2+-dependent, K+, Ca2+-Activated, Cardiomyocyte, Stem, Cells, ESCs, and, iPSC, 1041, Tocris Bioscience
16 Citations for 1-EBIO
Citations are publications that use Tocris products. Selected citations for 1-EBIO include:
Benton et al (2013) Iberiotoxin-sensitive and -insensitive BK currents in Purkinje neuron somata. J Neurophysiol 109 2528 PMID: 23446695
Cuppoletti et al (2013) Methadone but not mor. inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents. Cell Biochem Biophys 66 53 PMID: 22918821
Lai et al (2011) PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels. Oncol Rep 26 909 PMID: 21725609
Park et al (2011) Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 89 290 PMID: 20971723
Haddock et al (2011) Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS One 6 e16423 PMID: 21283658
Kusama et al (2005) Reduced hyperpolarization in endothelial cells of rabbit aortic valve following chronic nitroglycerine administration. Br J Pharmacol 146 487 PMID: 16056232
Wells et al (2016) Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice. Nature 532 58 PMID: 27007844
Cruse et al (2011) Functional KCa3.1 K+ channels are required for human fibrocyte migration. J Allergy Clin Immunol 128 1303 PMID: 21872912
Gamble-George et al (2016) Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife 5 PMID: 27162170
Choi et al (2013) Contradictory Effects of Superoxide and Hydrogen Peroxide on KCa3.1 in Human Endothelial Cells. Eur J Immunol 17 181 PMID: 23776393
Cuppoletti et al (2014) Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents. Am J Physiol Cell Physiol 307 C479 PMID: 25009109
Duffy et al (2007) Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Proc Natl Acad Sci U S A 37 1653 PMID: 17474152
Rau et al (2015) Increased Basolateral Amygdala Pyramidal Cell Excitability May Contribute to the Anxiogenic Phenotype Induced by Chronic Early-Life Stress. BMC Dermatol 35 9730 PMID: 26134655
Manaves et al (2004) Calcium and Vitamin D increase mRNA levels for the growth control hIK1 channel in human epidermal keratinocytes but functional channels are not observed. Korean J Physiol Pharmacol 4 7 PMID: 15200683
Banderali et al (2004) New insights on the voltage dependence of the KCa3.1 channel block by internal TBA. J Gen Physiol 124 333 PMID: 15452196
Bushart et al (2018) Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol 5 297 PMID: 29560375
Do you know of a great paper that uses 1-EBIO from Tocris? Please let us know.
Reviews for 1-EBIO
Average Rating: 5 (Based on 1 Review.)
Have you used 1-EBIO?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Epilepsy is a brain disease that affects 60 million people globally. More than 20 anti-seizure drugs are currently available, but these do not address the underlying causes of the condition. This poster summarizes current knowledge about the development of the condition and highlights some approaches that have disease-modifying effects in proof-of-concept studies.